Arvinas is based out of New Haven. Arvinas, Inc. operates as a bio-pharmaceutical company. The Company develops protein degradation therapeutics for cancers and other diseases. Arvinas serves health care industry worldwide. The firm last filed a Form D notice of exempt offering of securities on 2019-07-19. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
ARVINAS, INC.395 WINCHESTER AVE
NEW HAVEN CT 06511
Business Phone: 203-535-1456
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
2834-PHARMACEUTICAL PREPARATIONS